INM vs LOW · rev $4.9M vs P/E 18, rev $49.03B
InMed Pharmaceuticals Inc (INM) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
INM currently screens at market cap $5.2M. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the INM and LOW stock pages for the full models.
Not investment advice.